SCHEMBL29335260

SCHEMBL29335260

COc1ccc(S(=O)(=O)Nc2ccc(F)c(N)c2F)c(Cl)c1

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.47
▸ NPSR1 Q6W5P4 1/20 0.47
▸ MAPT P10636 1/20 0.47
▸ SLC40A1 Q9NP59 3/20 0.45
▸ ACLY P53396 6/20 0.44
▸ GAA P10253 1/20 0.43
▸ MAPK1 P28482 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ TP53 P04637 1/20 0.43
▸ TRPV4 Q9HBA0 1/20 0.43
▸ CCR2 P41597 2/20 0.42
▸ PTGES2 Q9H7Z7 1/20 0.42
▸ PIK3CD O00329 1/20 0.41
▸ PIK3CA P42336 1/20 0.41
▸ PIK3CB P42338 1/20 0.41
▸ PIK3CG P48736 1/20 0.41
▸ FABP4 P15090 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29335242 0.89 ALDH1A1 (0.50) ALDH1A1NPSR1MAPTSLC40A1ACLY
SCHEMBL29335243 0.86 ALDH1A1 (0.48) ALDH1A1NPSR1MAPTSLC40A1ACLY
SCHEMBL29335253 0.79 PTGES2 (0.53) ALDH1A1SLC40A1ACLYSMN1; SMN2CCR2
SCHEMBL29335270 0.78 ALDH1A1 (0.50) ALDH1A1NPSR1MAPTACLYGAA
SCHEMBL29335304 0.77 CCR2 (0.44) ALDH1A1NPSR1SLC40A1ACLYTP53
SCHEMBL29335266 0.75 FABP4 (0.50) ALDH1A1NPSR1MAPTACLYGAA
SCHEMBL3019464 0.75 CCR2 (0.59) ACLYCCR2PTGES2PIK3CDPIK3CA
SCHEMBL30897292 0.74 PTGES2 (0.61) SLC40A1ACLYCCR2PTGES2
Hydrochloric Acid SCHEMBL31588089 0.73 PTGES2 (0.60) SLC40A1ACLYCCR2PTGES2
SCHEMBL29335255 0.73 SLC40A1 (0.51) SLC40A1ACLYCCR2PTGES2PIK3CD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240239801-A1 PYRIMIDO[5,4,D]PYRIMIDINE COMPOUNDS, COMPOSITIONS COMPRISING THEM AND USES THEREOF Université de Montréal (CA) 2024-07-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240239801-A1 PYRIMIDO[5,4,D]PYRIMIDINE COMPOUNDS, COMPOSITIONS COMPRISING THEM AND USES THEREOF NRAS, BRAF, KRAS ALDH1A1 1786/4885NPSR1 3397/4885MAPT 3495/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback